Methods and compositions using monoclonal antibody to human T cells
US4657760A · kind A · utility
101Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 1985 |
| Grant date | Apr 14, 1987 |
| Priority date | — |
| Expiry date | Mar 4, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human T cells. The hybrid is formed by fusing splenocytes from immunized Balb/cJ mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.